|
China Risun Group Limited (1907.HK) DCF Valuation |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
China Risun Group Limited (1907.HK) Bundle
Looking to determine the intrinsic value of China Risun Group Limited? Our (1907HK) DCF Calculator integrates real-world data with extensive customization features, enabling you to adjust forecasts and enhance your investment strategies.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 21,606.3 | 41,968.3 | 47,110.9 | 50,306.8 | 51,919.6 | 67,039.1 | 86,561.7 | 111,769.4 | 144,317.9 | 186,344.9 |
| Revenue Growth, % | 0 | 94.24 | 12.25 | 6.78 | 3.21 | 29.12 | 29.12 | 29.12 | 29.12 | 29.12 |
| EBITDA | 3,517.9 | 5,956.5 | 5,051.4 | 4,767.5 | 3,824.7 | 7,781.9 | 10,048.1 | 12,974.3 | 16,752.5 | 21,631.0 |
| EBITDA, % | 16.28 | 14.19 | 10.72 | 9.48 | 7.37 | 11.61 | 11.61 | 11.61 | 11.61 | 11.61 |
| Depreciation | 806.6 | 1,475.5 | 1,556.0 | 2,549.0 | 2,429.7 | 2,721.6 | 3,514.2 | 4,537.5 | 5,858.9 | 7,565.1 |
| Depreciation, % | 3.73 | 3.52 | 3.3 | 5.07 | 4.68 | 4.06 | 4.06 | 4.06 | 4.06 | 4.06 |
| EBIT | 2,711.3 | 4,480.9 | 3,495.4 | 2,218.5 | 1,395.0 | 5,060.3 | 6,534.0 | 8,436.7 | 10,893.6 | 14,066.0 |
| EBIT, % | 12.55 | 10.68 | 7.42 | 4.41 | 2.69 | 7.55 | 7.55 | 7.55 | 7.55 | 7.55 |
| Total Cash | 1,299.1 | 2,588.8 | 1,532.9 | 1,364.6 | 2,472.8 | 3,071.7 | 3,966.3 | 5,121.3 | 6,612.6 | 8,538.3 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 1,201.4 | 3,341.2 | 3,355.3 | 3,785.0 | 4,622.2 | 4,970.3 | 6,417.7 | 8,286.6 | 10,699.8 | 13,815.6 |
| Account Receivables, % | 5.56 | 7.96 | 7.12 | 7.52 | 8.9 | 7.41 | 7.41 | 7.41 | 7.41 | 7.41 |
| Inventories | 1,646.2 | 2,390.6 | 3,517.7 | 3,719.6 | 3,361.5 | 4,645.8 | 5,998.8 | 7,745.7 | 10,001.3 | 12,913.8 |
| Inventories, % | 7.62 | 5.7 | 7.47 | 7.39 | 6.47 | 6.93 | 6.93 | 6.93 | 6.93 | 6.93 |
| Accounts Payable | 1,980.4 | 2,940.4 | 4,005.0 | 9,581.3 | 10,052.1 | 8,457.7 | 10,920.6 | 14,100.8 | 18,207.2 | 23,509.3 |
| Accounts Payable, % | 9.17 | 7.01 | 8.5 | 19.05 | 19.36 | 12.62 | 12.62 | 12.62 | 12.62 | 12.62 |
| Capital Expenditure | -2,038.3 | -4,008.6 | -4,782.7 | -2,260.0 | .0 | -4,509.0 | -5,822.1 | -7,517.6 | -9,706.8 | -12,533.5 |
| Capital Expenditure, % | -9.43 | -9.55 | -10.15 | -4.49 | 0 | -6.73 | -6.73 | -6.73 | -6.73 | -6.73 |
| Tax Rate, % | 81.6 | 81.6 | 81.6 | 81.6 | 81.6 | 81.6 | 81.6 | 81.6 | 81.6 | 81.6 |
| EBITAT | 2,243.4 | 3,662.3 | 2,942.8 | 2,801.2 | 256.7 | 3,715.0 | 4,796.9 | 6,193.7 | 7,997.4 | 10,326.4 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 144.6 | -795.0 | -360.6 | 8,035.1 | 2,678.0 | -1,299.3 | 2,151.5 | 2,778.1 | 3,587.1 | 4,631.7 |
| WACC, % | 4.11 | 4.08 | 4.15 | 4.6 | 2.27 | 3.84 | 3.84 | 3.84 | 3.84 | 3.84 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 10,147.1 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 4,724 | |||||||||
| Terminal Value | 256,816 | |||||||||
| Present Terminal Value | 212,719 | |||||||||
| Enterprise Value | 222,867 | |||||||||
| Net Debt | 30,892 | |||||||||
| Equity Value | 191,975 | |||||||||
| Diluted Shares Outstanding, MM | 4,364 | |||||||||
| Equity Value Per Share | 43.99 |
What You Will Get
- Genuine China Risun Data: Preloaded financial information – covering everything from revenue to EBIT – based on both actual and projected figures.
- Comprehensive Customization: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates.
- Immediate Valuation Adjustments: Automatic recalculations to assess the effects of changes on China Risun Group's fair value.
- Flexible Excel Template: Designed for easy modifications, scenario testing, and thorough projections.
- Efficient and Precise: Eliminate the need to build models from the ground up while ensuring accuracy and adaptability.
Key Features
- Comprehensive Data: Historical financial statements and forecasts pre-loaded for China Risun Group Limited (1907HK).
- Customizable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Real-Time Results: Observe the recalculation of China Risun Group Limited's (1907HK) intrinsic value instantly.
- Dynamic Visualizations: Engaging dashboard charts showcase valuation outcomes and essential metrics.
- Designed for Precision: A reliable tool tailored for analysts, investors, and financial professionals.
How It Functions
- Download: Obtain the pre-configured Excel file containing China Risun Group Limited's (1907HK) financial data.
- Customize: Modify projections such as revenue growth, EBITDA %, and WACC to suit your analysis.
- Update Instantly: The calculations for intrinsic value and NPV refresh in real-time as you make changes.
- Evaluate Scenarios: Generate various forecasts and compare results immediately.
- Make Informed Choices: Leverage the valuation outputs to shape your investment approach.
Why Choose This Calculator for China Risun Group Limited (1907HK)?
- Precision: Utilizes actual financial data from China Risun Group for reliable calculations.
- Adaptability: Allows users to easily test and adjust inputs to suit their needs.
- Efficiency: Avoid the complexities of constructing a DCF model from the ground up.
- High-Quality: Crafted with the accuracy and usability expected by top financial executives.
- Intuitive: Simple to navigate, making it accessible for users without advanced financial skills.
Who Should Use This Product?
- Investors: Assess China Risun Group Limited’s valuation before making stock transactions.
- CFOs and Financial Analysts: Optimize valuation methodologies and evaluate financial forecasts.
- Startup Founders: Understand the valuation strategies of major companies like China Risun Group Limited (1907HK).
- Consultants: Create comprehensive valuation reports for your clients featuring China Risun Group Limited (1907HK).
- Students and Educators: Leverage real-world examples to learn and teach valuation practices using data from China Risun Group Limited (1907HK).
Contents of the Template
- Operating and Balance Sheet Data: Pre-filled historical data and forecasts for China Risun Group Limited (1907HK), including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for calculating the Weighted Average Cost of Capital (WACC), featuring parameters such as Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Customizable Discounted Cash Flow models that illustrate intrinsic value along with detailed calculations.
- Financial Statements: Pre-loaded annual and quarterly financial statements to facilitate in-depth analysis.
- Key Ratios: Provides profitability, leverage, and efficiency ratios relevant to China Risun Group Limited (1907HK).
- Dashboard and Charts: A visual summary of valuation outputs and assumptions for straightforward analysis of results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.